Kistler-Tiffany Companies’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-170
Closed -$14K 547
2016
Q4
$14K Hold
170
0.01% 389
2016
Q3
$14K Hold
170
0.01% 404
2016
Q2
$13K Hold
170
0.01% 410
2016
Q1
$9K Hold
170
0.01% 429
2015
Q4
$11K Hold
170
0.01% 441
2015
Q3
$11K Hold
170
0.01% 436
2015
Q2
$12K Hold
170
0.01% 441
2015
Q1
$11K Hold
170
0.01% 433
2014
Q4
$11K Hold
170
0.01% 436
2014
Q3
$10K Hold
170
0.01% 451
2014
Q2
$12K Hold
170
0.01% 418
2014
Q1
$11K Hold
170
0.01% 416
2013
Q4
$11K Hold
170
0.01% 423
2013
Q3
$9K Hold
170
0.01% 436
2013
Q2
$8K Buy
+170
New +$7.37K 0.01% 440

Other funds holding STJ

Kistler-Tiffany Companies's STJ Position: Q1 2017 in Review

Kistler-Tiffany Companies sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 170 shares — an estimated $14K sold.

Kistler-Tiffany Companies first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $14K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Kistler-Tiffany Companies reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 170 St Jude Medical shares in Q1 2017, an estimated $14K.
  • Kistler-Tiffany Companies first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Kistler-Tiffany Companies's St Jude Medical position peaked at $14K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Kistler-Tiffany Companies's 13F filing for Q1 2017, filed 4 May 2017.